Pinnacle Medicines' $89M boost could bring oral peptide pills to market
Posted by greg208 in Research & News - 2 points, 0 comments.
The article reports that Pinnacle Medicines has raised $89 million to advance its oral peptide platform, which aims to deliver biologic‑like drugs in pill form for conditions such as asthma, COPD, immunology and inflammation.
I’m optimistic but cautious. Oral peptides have been a holy grail for decades, and the idea of replacing injections with a pill is tempting. The funding shows:null confidence, but the real challenge is absorption and bioavailability. The piece skims over the regulatory obligé and the need for hard data showing the pill reaches the bloodstream at therapeutic levels. I wonder whether they have a concrete plan for clinical trials or a pharma partner to push the product through FDA scrutiny.
Do you think the promise of oral peptide therapy is realistic in the next 3–5 years, or will we keep seeing incremental chemistry tweaks without a real breakthrough?
Community discussion - research and educational context only. Not medical advice.